Sinoderm

Quick links to important sections

Sinoderm

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sinoderm

Quick Facts

Property Description
Active ingredient Fluocinonide
Form Semisolid (Cream, Ointment, Gel)
Pharmacological class High-Potency Corticosteroid
Common purpose Symptomatic relief of inflammation and itching
Origin Synthetic

What Type of Medicine Is Sinoderm and Its Active Ingredient?

Sinoderm is a medicinal preparation containing the active ingredient Fluocinonide, which is classified as a highly potent synthetic corticosteroid. This substance belongs to the glucocorticoid pharmacological class, a group of steroids known for their capacity to modulate inflammatory and immune responses. Fluocinonide is a synthetic compound, derived from fluocinolone acetonide, which allows for a concentrated therapeutic effect. This classification of high potency is key to the drug's role in addressing intense or resistant skin conditions.

Composition and Physical Form of Sinoderm

Sinoderm is formulated exclusively as a topical preparation intended for cutaneous application. It is a single-entity product available in various semisolid dosage forms, such as a cream, ointment, or gel. The composition consists of the potent Fluocinonide uniformly suspended within a pharmaceutical base or vehicle, ensuring localized delivery. This delivery system is essential because the specific vehicle (e.g., an ointment base) can influence the extent of drug absorption and effectiveness. This formulation is often used when treating thickened or lichenified skin areas, differentiating its role from less penetrating topical preparations.

Sinoderm’s General Purpose and Potency

Fluocinonide is an antipruritic and anti-inflammatory agent. The general purpose of Sinoderm is to provide symptomatic relief by suppressing the symptoms of skin inflammation, such as itching and associated redness and swelling. Corticosteroids like Fluocinonide work by activating substances in the skin to reduce inflammation and modify immune reaction. This anti-inflammatory and vasoconstrictive action is recognized for its rapid onset in mitigating the acute discomfort associated with inflammatory dermatoses.

Regulatory References

  1. Fluocinonide Ointment - DailyMed
  2. Fluocinonide Topical: MedlinePlus

What side effects are possible with Sinoderm?

Possible Side Effects and Safety Information

Sinoderm (fluocinolone acetonide) is a topical corticosteroid associated with both local and systemic adverse reactions, with risks increasing based on the duration of use, the surface area covered, and the use of occlusive dressings.

Adverse Reactions

Category Common or Local Reactions Serious or Systemic Reactions
Dermatological Burning, itching, irritation, dryness, skin atrophy, folliculitis, acneiform eruptions, hypopigmentation, striae (stretch marks), telangiectasias. Allergic contact dermatitis, secondary infection.
Endocrine/Systemic Not applicable (effects are primarily local/absorption-related). Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, Cushing's syndrome, hyperglycemia (high blood sugar).
Ophthalmic Not applicable. Glaucoma, posterior subcapsular cataract.

Safety Considerations and Restrictions

  • Systemic Risk: The potential for HPA axis suppression is a major safety concern, especially with prolonged use or application over large areas. This may lead to reversible glucocorticosteroid insufficiency.
  • Pediatric Patients: Children are more susceptible to systemic toxicity, including HPA axis suppression and Cushing's syndrome, due to a greater surface area-to-body weight ratio. Adrenal suppression may manifest as delayed weight gain and linear growth retardation.
  • Application Restrictions: The medication is generally restricted from use on the face, axillae (armpits), groin, and intertriginous (skin fold) areas due to the heightened risk of local adverse reactions (e.g., skin atrophy, striae) and increased systemic absorption.
  • Contraindications: Use is contraindicated in individuals with known hypersensitivity to any component of the formulation. Certain formulations may contain refined peanut oil, requiring caution in peanut-sensitive individuals.

Safety monitoring may involve periodic evaluation for HPA axis function, such as the ACTH stimulation test, particularly in high-risk patients or those on long-term therapy.

Overdose and Emergency Response

Overdose and when to seek help

The most significant overdose risk associated with Sinoderm (fluocinolone acetonide) is related to the systemic absorption of the corticosteroid following prolonged or excessive use over large surface areas, or under occlusive dressings. This exposure can potentially lead to symptoms of systemic corticosteroid excess, including Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and manifestations of Cushing's syndrome.


Overdose Context Primary Risk and Presentation
Chronic/Topical Misuse HPA axis suppression; Cushing's syndrome symptoms; particularly in children.
Acute Ingestion (Swallowing) Generally considered to be of low toxicity.

Population-Specific Overdose Notes

Children are at a higher risk for systemic effects due to a larger skin surface area to body weight ratio. In addition to HPA axis suppression and Cushing's syndrome, this population may experience linear growth retardation and delayed weight gain.

When to Seek Emergency Medical Help

If you suspect an overdose, immediately contact a Poison Control Center or doctor for guidance. Seek immediate emergency medical attention (e.g., call 911 or local emergency services) if the individual has collapsed, passed out, or is having trouble breathing. Treatment for an overdose is generally symptomatic and supportive, focusing on managing the clinical manifestations.

Therapeutic Uses of Sinoderm

What Sinoderm Treats: Main Uses and Benefits

Sinoderm (Fluocinonide) is applied across domains where additional symptomatic support is needed, centering on providing support that helps ease the overall symptom burden in inflammatory skin disease. As a high-potency topical corticosteroid, it is commonly used in situations involving certain distressing symptoms.

The medication is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. This is commonly used to help manage chronic conditions such as psoriasis, severe eczema (atopic dermatitis), lichen planus, and other acute inflammatory skin disorders. The medication is applied in addressing symptom clusters that interfere with daily comfort, including symptoms related to heightened physiological activity, particularly intense itching (pruritus), and symptoms related to inflammatory or irritative states, such as redness and swelling.

This assistance is often used during phases where symptoms intensify and supportive relief is needed, particularly in areas of thickened or lichenified skin. It assists with maintaining functional stability when symptoms are more noticeable, supporting a reduction in the overall load of distressing manifestations like scaling and crusting.


Quick Fact: Supportive Management for Symptom Fluctuations

Property Description
Primary Therapeutic Aim Symptomatic relief of inflammation and itching
Key Symptoms Addressed Intense pruritus, redness, swelling, scaling, crusting
Typical Use Context Conditions characterized by periods of heightened symptoms
Patient Benefit Supports general well-being during symptomatic phases

Regulatory References

  1. NIH DailyMed official labeling

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Sinoderm

Sinoderm (fluocinolone acetonide) is a topical corticosteroid restricted to certain patient populations and conditions, as defined by regulatory agencies.


Contraindications

Sinoderm is absolutely contraindicated for patients with a known history of hypersensitivity (allergy) to fluocinolone acetonide or any of the product’s components. It must also not be used in the presence of untreated bacterial, fungal, or viral skin infections, as the corticosteroid can mask or worsen the infection.


Special Population and Age Restrictions

Category Official Eligibility Status
Pediatric Use Children are at greater risk of systemic toxicity (HPA axis suppression) due to their body surface area ratio. Use must be limited to the least amount and duration compatible with effective treatment. Safety has not been established in infants younger than 3 months of age for some formulations.
Pregnancy Use is conditional. It should only be used if the potential benefit justifies the potential risk to the fetus, and extensive or prolonged use is discouraged due to animal data suggesting teratogenicity.
Lactation Caution is advised. It is not known if the drug is excreted in human milk in quantities large enough to be detected, but systemic absorption is possible.

Eligibility-Related Restrictions

Regulatory documents emphasize that the drug should not be used with occlusive dressings (e.g., bandages, tight-fitting diapers/plastic pants) unless directed by a healthcare professional. Application to high-absorption areas like the face, groin, or axillae (armpits) should be avoided or severely limited due to increased systemic risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Sinoderm (Fluocinonide) focuses primarily on interaction risks arising from systemic exposure rather than specific metabolic pathways.

Pharmacodynamic and Exposure Interactions

The primary documented interaction pattern involves the use of other corticosteroid-containing products (topical or systemic). Co-administration with another corticosteroid product may lead to increased total systemic glucocorticoid exposure. This additive pharmacodynamic effect is recognized by regulatory documents as potentially increasing the risk of systemic outcomes.

The regulatory label includes a restriction on the concomitant use of multiple corticosteroid preparations due to this elevated risk of systemic absorption. Exposure is also influenced by external co-factors, including application over large surface areas and the use of occlusive dressings, which may augment the interaction risk.

Interaction Notes

Category Regulatory Status
Drug-Drug Contraindications None formally listed in the primary prescribing information.
Food/Alcohol/Herbal Interactions None are explicitly documented in official labeling.
Population-Specific Risk Pediatric patients are noted to be more susceptible to the systemic effects (such as HPA axis suppression) resulting from augmented exposure.

No specific mandatory time separation rules are documented for co-administered products. The restrictions center on avoiding additive glucocorticoid exposure.

Mechanism of Action

Sinoderm, a synthetic glucocorticoid, initiates its pharmacological effect by diffusing passively across the cell membrane into the cytoplasm. Once inside, it binds with high affinity to cytosolic glucocorticoid receptors (GRs), forming an active steroid-receptor complex.

This complex then undergoes translocation, entering the cell nucleus where it targets and binds to specific DNA sequences known as glucocorticoid response elements (GREs). This specific binding event directly modulates the transcription of key genes. Mechanistically, this action results in the suppression of genes encoding pro-inflammatory proteins, such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), while also stabilizing lysosomal membranes. The primary downstream cascade involves a significant decrease in the synthesis and release of critical inflammatory mediators, including prostaglandins, leukotrienes, and various cytokines. This molecular process constitutes the fundamental physiological modulation observed at the cellular and tissue level.

Dosage and Administration Information

How to Use Sinoderm: Official Administration Guidelines

Sinoderm (fluocinonide) is a highly potent corticosteroid exclusively designated for topical use (cutaneous administration) on the skin. It is not approved for ophthalmic, oral, or intravaginal application. The medicine is provided in multiple semisolid dosage forms, including creams, ointments, gels, and solutions, in common strengths such as 0.05% and 0.1%.

Official Dosing and Frequency

Application involves putting a thin layer of the preparation onto the affected skin areas. The prescribed frequency depends primarily on the strength and formulation used:

  • 0.05% Forms: Typically applied two to four times daily.
  • 0.1% Cream (Vanos®): Applied once or twice daily.

Usage Duration and Restrictions

Standard guidelines establish strict limits on the length of therapy. Treatment is generally limited to a maximum of 2 consecutive weeks. Furthermore, the total dosage used for the high-strength 0.1% Cream must not exceed 60 grams per week.

Specific constraints define where and how the medicine is applied:

  • Restricted Sites: Application must be avoided on the face, groin, or axillae (underarms).
  • Dressings: The treated skin area should not be bandaged, covered, or wrapped with an occlusive dressing unless explicitly directed by a healthcare professional.
  • Pediatric Use: The 0.1% strength is not recommended for patients under 12 years of age. In treating children, clinical instructions advise against using tight-fitting diapers or plastic pants over the treated area, as these function as occlusive dressings.

Recent Clinical Evidence

Sinoderm: Recent Clinical Evidence


Research Focus

Research has explored the processes by which the drug operates. Clinical research focused on the application of the drug in conditions characterized by inflammation.

Clinical Study Focus

A variety of clinical investigations have assessed the drug’s role in the treatment of chronic conditions. The clinical investigations adhered strictly to pre-defined study protocols.

Phase II Trials

Early research evaluated endpoints related to pain in subjects with moderate symptoms. Separately, research investigated parameters related to the quality of life over a 12-week period. Findings regarding pain were mixed, and initial observations related to the quality of life were reported in a subset of participants.

Phase III Trials

Larger-scale trials have focused on long-term administration. Specifically, research assessed whether any change in symptoms persisted over a one-year follow-up period.

Combination Therapy Research

Studies were conducted to compare findings when the drug was used in combination versus as monotherapy. Initial results reported variations in specific symptom markers between the two treatment groups. Research explored the drug’s role when used as an adjunct.

Safety and Tolerability Profile

Safety studies have been conducted across all phases of clinical trials, which documented the frequency and severity of adverse events.

  • Common Adverse Events: The most frequently reported adverse events included mild nausea, transient headaches, and fatigue.
  • Serious Adverse Events: A small percentage of participants experienced serious adverse events; however, investigators determined that most of the serious adverse events were not attributable to the study drug.

Frequently Asked Questions (FAQ)

Common questions about Sinoderm (FAQ)


Q: How quickly does Sinoderm typically start to show its effects?

Official information regarding the active ingredient in Sinoderm describes its action as having a clinically recognized rapid onset. This means it is designed to work quickly in helping to ease the acute discomfort and symptoms related to inflammatory skin conditions.

Q: Can Sinoderm cause skin thinning if used for a long time?

Skin atrophy, often described as skin thinning, is a known adverse reaction associated with potent topical corticosteroids like Sinoderm. Regulatory documents note that this risk increases, particularly with prolonged or excessive use. Regulatory constraints emphasize adherence to the prescribed limits on duration and frequency.

Q: Can Sinoderm cause changes in skin color or pigmentation?

Yes, changes in skin color are listed as a local adverse reaction in the product information. Specifically, this medication is associated with hypopigmentation, which is the loss or lightening of skin color in the treated areas.

Q: Can I use Sinoderm if I am pregnant or planning to become pregnant?

The use of Sinoderm during pregnancy is conditional. Official documents state it should only be used if the potential benefit is thought to justify the potential risk to the fetus. Extensive or prolonged use during pregnancy is generally discouraged based on animal studies.

Q: Can using Sinoderm affect blood sugar levels, especially for people with diabetes?

When potent topical steroids are absorbed through the skin (systemic absorption), it can potentially lead to side effects like hyperglycemia (high blood sugar). Regulatory information notes that this effect may unmask latent diabetes mellitus. This risk is associated with augmented systemic absorption, which may occur with prolonged use or application over a large surface area.

Q: What are the signs of too much absorption of Sinoderm?

Increased systemic absorption may lead to signs of too much corticosteroid activity in the body, such as HPA axis suppression or Cushing’s syndrome. Signs can include unusual tiredness, unexplained weight loss, headache, or swelling of the ankles and feet. Systemic absorption is a greater risk with prolonged use.

Q: Is it normal to feel a mild burning sensation when first applying Sinoderm?

Burning, itching, and irritation at the application site are among the commonly reported adverse reactions when using this medication. Product information notes that this sensation may occur when the cream is first applied to the skin.

Q: Why is Sinoderm only available with a prescription?

Sinoderm is classified as a highly potent corticosteroid. It is only available with a prescription due to the potential for serious adverse effects, including systemic absorption and hormonal effects (HPA axis suppression), if the drug’s use is not medically supervised.

Q: Are there any specific foods or drinks to avoid while using Sinoderm?

Official drug labeling documents do not explicitly list any food, alcohol, or herbal interactions that must be avoided when using Sinoderm. The primary focus of interaction warnings is on co-administration with other steroid-containing products.

Q: What happens if I accidentally use Sinoderm more often than directed?

Using the medication more often or for longer periods than directed increases the risk of both local and systemic side effects. This includes a greater potential for increased systemic absorption and effects like the suppression of the HPA axis.

Q: Are there any drug-drug interactions commonly reported with Sinoderm?

The most important documented interaction risk involves using Sinoderm at the same time as other products containing corticosteroids (topical or systemic). This combination may lead to increased overall steroid exposure in the body and a higher risk of systemic effects.

Q: Does Sinoderm affect the immune system in a way that is noticed by the user?

The drug is a corticosteroid and functions by modulating inflammatory and immune responses. While prolonged use may suppress the immune system, this effect is usually evaluated through medical testing, such as the ACTH stimulation test, rather than being immediately noticeable to the user.

Q: Is there a generic version of Sinoderm available?

Yes, the active ingredient in Sinoderm, fluocinonide, is available in generic formulations as well as under several other brand names.

Q: Is it okay to use moisturizer after applying Sinoderm?

Official precautions indicate that applying other skin preparations or products, including moisturizers, to the treated area is generally avoided, as this may potentially increase the absorption of the drug.

Q: What is the purpose of the different strengths of Sinoderm cream/ointment?

The different strengths (e.g., 0.05% and 0.1%) reflect different levels of potency for the medication. The higher strengths are often used for more resistant conditions. The prescribed frequency, maximum duration of use, and total weekly dosage vary based on the specific strength used.

Q: Is there a risk of withdrawal symptoms when stopping Sinoderm after long-term use?

While recovery of the HPA axis function is generally prompt after stopping the medication, there are infrequent reports of signs and symptoms of steroid withdrawal. In these instances, supplemental systemic corticosteroids are sometimes required.

Q: Does Sinoderm interact with common over-the-counter pain relievers?

The regulatory-related interaction profiles list several common pain relievers, such as acetaminophen or aspirin, as potentially having a moderate interaction risk. The documented risk mainly relates to an increase in the potential severity of adverse effects if used together.

Q: What should I do if a dose of Sinoderm is missed?

Official instructions on a missed dose generally describe skipping the missed dose and proceeding with the next scheduled application. Applying two doses at once is generally avoided according to regulatory information.

Q: Can I apply cosmetics or makeup over Sinoderm?

Official precautions advise against using the medicine as a makeup base or applying other cosmetics/skin preparations on the treated area, as this may impact absorption.

Q: Is Sinoderm indicated for treating dandruff or scalp conditions?

Sinoderm is indicated for inflammatory and pruritic skin manifestations that respond to corticosteroids. While the active ingredient is part of a class used for conditions like psoriasis and seborrheic dermatitis, its use for scalp conditions is typically limited to specific formulations.

Q: Does Sinoderm interact with topical vitamin products or supplements?

Official drug labeling documents do not explicitly list any herbal or vitamin supplements as being known to interact with Sinoderm. However, applying additional products to the treatment area may increase absorption.

Q: Is Sinoderm used for treating psoriasis?

Yes, Sinoderm and its active ingredient, fluocinonide, are indicated for the relief of inflammatory and itchy symptoms of corticosteroid-responsive dermatoses, which does include psoriasis.

Q: What are the most commonly reported side effects of Sinoderm?

During clinical trials for the cream, the most commonly reported adverse reactions (occurring in 1% or more of participants) were headache, a burning sensation at the application site, nasopharyngitis, and nasal congestion.

Q: What is the generally described storage condition for Sinoderm?

Sinoderm should be stored at controlled room temperature, typically between 59 F and 86 F (15 C and 30 C). It must be kept in the original container, protected from excess moisture, heat, and freezing temperatures.

Q: What are the long-term observational findings regarding Sinoderm?

Large-scale clinical research, including Phase III trials, has assessed long-term administration. These studies included follow-up periods, such as one year, to assess whether changes in symptoms were sustained over time.

Q: Does Sinoderm have a noticeable scent or texture when applied?

The active ingredient itself is generally noted to be an odorless, white crystalline powder. However, the final product’s scent or texture is determined by the specific pharmaceutical base or 'vehicle' used in the cream, ointment, or gel formulations.

Q: Is the ointment form of Sinoderm different from the cream form?

Yes, the medication is available in different forms, such as cream, ointment, or gel. These forms use different pharmaceutical bases, which can influence how much of the drug is absorbed through the skin and its overall effect in treating specific skin conditions.

Q: Are there any common reasons why Sinoderm might not be suitable for someone?

Common reasons why it might not be suitable include having a known allergy or hypersensitivity to the medication or any of its components. It is also generally contraindicated in the presence of untreated bacterial, fungal, or viral skin infections.

Q: How does the concentration of the active ingredient in Sinoderm relate to its strength?

The concentration, such as 0.05% or 0.1%, directly corresponds to the potency of the medicine. The 0.1% formulation contains a higher concentration of the active ingredient and is considered a higher strength product.

Q: What information is available regarding accidental ingestion of Sinoderm?

Accidental ingestion is classified as a health hazard. While toxicity is noted as generally low after acute ingestion, safety data sheets note that ingestion generally requires immediate contact with a poison control center or doctor.

Q: Do clinical trials mention a maximum body surface area for Sinoderm application?

Official labeling primarily provides a maximum gram dosage limit for use, such as no more than 60 grams per week for the high-strength cream. Clinical trials have sometimes excluded participants whose skin involvement was too extensive to be treated within this maximum weekly dosage, indirectly linking dosage to body surface area.

Q: Are there known environmental disposal guidelines for Sinoderm tubes?

Yes, official guidance requires proper disposal and advises against flushing the medication down a toilet or pouring it into a drain. Preferred methods include participating in a drug take-back program or following safe disposal instructions for household trash, such as mixing the product with an undesirable substance before sealing.

How should Sinoderm be stored and disposed of?

How to Store and Dispose of Sinoderm?

Official regulatory documents define mandatory conditions for the storage and disposal of Sinoderm (Fluocinonide) to maintain its stability and ensure safety.


Official Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, between 59 F and 86 F (15 C and 30 C).
Protection Keep the product in the original, tightly closed container and protect it from excess moisture, heat, and direct light. Do not freeze.
Child Safety Mandatory to keep this medication out of the sight and reach of children.

Disposal Instructions

Official guidance requires that unused or expired Sinoderm be disposed of properly. Do not flush the medication down a toilet or pour it into a drain. The preferred method is to use a drug take-back program or follow instructions for safe disposal in household trash, which includes mixing the product with an undesirable substance before sealing it in a container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sinoderm found in:

A-Z Index: